Jean Sibilia Selected Research

Jean Sibilia Research Topics

Disease

77	Rheumatoid Arthritis 09/2021 - 02/2002
23	Inflammation (Inflammations) 09/2021 - 03/2003
22	Arthritis (Polyarthritis) 10/2022 - 07/2002
15	Infections 12/2021 - 04/2002
15	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2002
14	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 12/2006
13	Fatigue 09/2021 - 01/2009
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2005
13	Systemic Scleroderma (Systemic Sclerosis) 02/2020 - 12/2002
11	Pain (Aches) 01/2020 - 04/2002
10	COVID-19 01/2022 - 01/2020
9	Neoplasms (Cancer) 01/2020 - 01/2005
9	Necrosis 01/2019 - 06/2004
7	Joint Diseases (Joint Disease) 09/2021 - 07/2002
6	Muscular Diseases (Myopathy) 01/2018 - 10/2010
5	Rheumatic Diseases (Rheumatism) 10/2021 - 02/2008
5	Osteoarthritis 09/2021 - 06/2004
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2018 - 03/2003
5	Neutropenia 09/2017 - 04/2002
4	Vasculitis (Vasculitides) 02/2020 - 09/2011
4	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020 - 01/2007
4	Dermatomyositis (Dermatopolymyositis) 01/2019 - 07/2011
4	Antisynthetase syndrome 01/2018 - 12/2012
4	Sepsis (Septicemia) 09/2017 - 08/2002
4	Agranulocytosis (Granulocytopenia) 01/2017 - 04/2002
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2015 - 04/2003
4	Ulcer 02/2008 - 11/2003
3	Reactive Arthritis (Reiter Disease) 09/2021 - 01/2008
3	Takayasu Arteritis (Arteritis, Takayasu's) 10/2020 - 05/2012
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2020 - 01/2018
3	Pneumonia (Pneumonitis) 01/2020 - 04/2002
3	Synovitis 01/2019 - 12/2005
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2015 - 03/2011
3	Myocardial Infarction 09/2006 - 03/2004
3	Hemorrhage 04/2004 - 11/2003
2	Psoriatic Arthritis 09/2021 - 05/2011
2	Glomerulonephritis 02/2020 - 01/2019
2	Multiple Sclerosis 01/2020 - 03/2012
2	Skin Neoplasms (Skin Cancer) 01/2020 - 01/2015
2	Microscopic Polyangiitis 01/2020 - 01/2018
2	Lyme Disease (Disease, Lyme) 01/2019 - 01/2009

Drug/Important Bio-Agent (IBA)

33	Rituximab (Mabthera)FDA Link 10/2020 - 10/2008
18	Biological ProductsIBA 01/2022 - 08/2003
18	AntibodiesIBA 01/2022 - 01/2006
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 07/2003
17	Methotrexate (Mexate)FDA LinkGeneric 07/2017 - 06/2002
15	tocilizumab (atlizumab)FDA Link 05/2021 - 06/2010
14	Pharmaceutical PreparationsIBA 10/2021 - 04/2002
13	Antirheumatic Agents (DMARD)IBA 01/2020 - 07/2006
13	AutoantibodiesIBA 10/2019 - 03/2003
13	Abatacept (Orencia)FDA Link 01/2019 - 08/2005
10	CytokinesIBA 10/2022 - 06/2004
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
9	Infliximab (Remicade)FDA Link 10/2020 - 07/2003
8	GlucocorticoidsIBA 10/2021 - 07/2006
8	Biomarkers (Surrogate Marker)IBA 09/2021 - 04/2011
8	Etanercept (Enbrel)FDA Link 07/2014 - 04/2003
7	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2003
7	ametantrone (HAQ)IBA 01/2019 - 11/2003
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 11/2003
6	B-Cell Activating FactorIBA 01/2015 - 01/2006
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2022 - 07/2014
5	AntigensIBA 01/2021 - 11/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 08/2002
5	Rheumatoid FactorIBA 10/2013 - 08/2003
4	VaccinesIBA 10/2022 - 06/2017
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2020 - 10/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2006
4	Immunoglobulin G (IgG)IBA 01/2020 - 03/2003
4	InterferonsIBA 01/2020 - 05/2010
4	Tumor Necrosis Factor InhibitorsIBA 09/2019 - 12/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 06/2013
4	SteroidsIBA 06/2017 - 07/2002
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2015 - 09/2006
4	Peptides (Polypeptides)IBA 05/2015 - 11/2004
4	Monoclonal AntibodiesIBA 05/2015 - 10/2008
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015 - 03/2003
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2013 - 12/2006
3	micaIBA 09/2021 - 06/2007
3	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 01/2016
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 04/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017 - 04/2002
3	C-Reactive ProteinIBA 12/2016 - 11/2003
3	Ligases (Synthetase)IBA 07/2015 - 12/2006
3	Adalimumab (Humira)FDA Link 07/2014 - 11/2009
3	cyclic citrullinated peptideIBA 10/2013 - 01/2006
3	Antinuclear AntibodiesIBA 03/2010 - 01/2005
2	COVID-19 VaccinesIBA 12/2021 - 10/2021
2	Calcium PyrophosphateIBA 09/2021 - 03/2013
2	LigandsIBA 09/2021 - 01/2005
2	Uric Acid (Urate)IBA 09/2021 - 01/2020
2	CholesterolIBA 05/2021 - 07/2006
2	rheinIBA 01/2021 - 01/2019
2	Antimalarials (Antimalarial Agents)IBA 01/2021 - 08/2018
2	Vitamin D FDA LinkGeneric 01/2020 - 11/2018
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 03/2003

Therapy/Procedure

41	Therapeutics 10/2022 - 02/2002
8	Biological Therapy 01/2019 - 12/2005
3	Contraindications 03/2012 - 07/2006
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2019 - 01/2017